JPRN-UMIN000021818已完成未知
Efficacy and safety of phosphate binders, ferric citrete hydrate and lanthunam carbohydrate, in patients undergoing maintenance hemodialysis - Efficacy of phosphate binders
Divisions of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine0 个研究点目标入组 60 人开始时间: 2016年4月7日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Active gastrointestinal hemorrhage,(2) malignant tumor, (3) liver cirrhosis and (4) hematological disorder.
研究者
相似试验
已完成
不适用
Efficacy and safety of phosphate binders in patients on hemodialysisPatients undergoing maintenance hemodialysisJPRN-UMIN000031733ihon University School of Medicine60
已完成
不适用
Evaluation for new Phosphate Iron-based binder , Sucroferric Oxyhydroxide in Dialysis patient for E.B.MhyperphosphatemiaJPRN-UMIN000023648Osaka University Graduate School of Medicine Department of Nephrology200
未知
不适用
Effect of iron containing phosphate binder on iron metabolism of patients undergoing maintenance hemodialysis.Chronic kidney diseaseJPRN-UMIN000023700Hyogo College of Medicine300
已完成
Unknown
The effect of novel iron-containing phosphate binder,ferric citrate, to serum P,Ca,and iron metabolic markers on HD patients.HD PatientsJPRN-jRCT1090220207Shigeru Miyazaki20
已完成
不适用
Efficacy of the iron-based phosphate binder in patients on peritoneal dialysis.chronic renal failureJPRN-UMIN000034472Saiseikai Yokohamashi Tobu Hospital100